Human dopamine D3 receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism

Molecular Pharmacology

Volumn 56, Issue 5, 1999, Pages 1025-1030

  Cussac, Didier ^a   Newman Tancredi, Adrian ^a,b   Pasteau, Valerie ^a   Millan, Mark J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 DIPROPYLAMINO 1,2,3,4 TETRAHYDRO 6 (4 METHOXYPHENYLSULFONYLMETHYL)NAPHTHALENE; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 7 DIPROPYLAMINO 2,3,5,6,7,8 HEXAHYDRONAPHTHO[2,3 B]FURAN; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; GENISTEIN; HALOPERIDOL; LAVENDUSTIN A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL;

EID: 0032706897     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.5.1025     Document Type: Article

References (41)

1. Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS and Moscat J (1993) Protein kinase C ζ isoform is critical for mitogenic signal transduction. Cell 74:555-563.
2. + + or protein kinase C in alpha-1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells. Mol Pharmacol 55:296-303.
3. Casabona G (1997) Intracellular signal modulation: A pivotal role for protein kinase C. Prog Neuropsychopharmacol Biol Psychiatry 21:407-425.
4. Daub H, Weiss FU, Wallasch C and Ullrich A (1996) Role of transactivation of the EGF receptor in signaling by G protein-coupled receptors. Nature (Lond) 379:557-560.
5. Diaz-Meco MT, Lozano J, Municio MM, Berra E, Frutos S, Sanz L and Moscat J (1994) Evidence for the in vitro and in vivo interaction of Ras with protein kinase C ζ. J Biol Chem 269:31706-31710.
6. Dikic I, Tokiwa G, Lev S, Courtneidge SA and Schlessinger J (1996) Role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature (Lond) 383:547-550.
7. Faure M, Voyno-Yasenetskaya TA and Bourne HR (1994) cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269:7851-7854.
8. 1A receptor via G-protein βγ subunit initiated pathway. Biochemistry 35:13716-13722.
9. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller H-J and Johannes F-J (1996) Inhibition of protein kinase μ by various inhibitors. Differentiation from protein Kinase C isoenzymes. FEBS Lett 392:77-80.
10. fyn in human platelets, Mol Cell Biol 10:3806-3809.
11. Hawes BE, van Biessen T, Koch WJ, Luttrell LM and Lefkowitz RJ (1995) Distinct pathways of Gi-and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem 270:17148-17153.
12. Igishi T and Gutkind JS (1998) Tyrosine kinases of the Src family participate in signaling to MAP kinase from both Gq and Gi-coupled receptors. Biochem Biophys Res Commun 244:5-10.
13. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marnié D and Rapp UR (1993) Protein kinase Ca activates RAF-1 by direct phosphorylation Nature (Lond) 364:249-252
14. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252.
15. Liscovitch M and Cantley LC (1994) Lipid second messengers. Cell 77:329-334.
16. Lopez-Ilasaca M (1998) Signaling from G-protein-coupled-receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 56:269-277.
17. Lopez-Ilasaca M, Crespo P, Pelicci PG, Gutkind JS and Wetzker R (1997) Linkage of G-protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase γ. Science (Wash DC) 275:394-397.
18. 2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J Neurochem 71:980-990.
19. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D and Schächtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 268:9194-9197.
20. 2 receptors elicits prolactin secretion and catalepsy. J Pharmacol Exp Ther 275:885-898.
21. Missale C, Nash SR, Robinson SW, Jaber M and Caron MG (1998)) Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
22. Nakanishi H, Brewer KA and Exton JH (1993) Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 268:13-16.
23. 35S]thio)triphosphate binding and antibody study. Mol Pharmacol 55:564-574.
24. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K and Nishizuka Y (1989) PYotein kinase C ζ subspecies from rat brain : its structure, expression and properties. Proc Natl Acad Sci USA 86:3099-3103.
25. Pang L, Sawada T, Decker SJ and Saltiel AR (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J BM Chem 270:13585-13588.
26. Pawson T (1995) Protein modules and signaling networks. Nature (Lond) 373:573-580.
27. 3 receptor in a transfected NG108-15 neuroblastoma-glioma hybrid cell line. Eur J Pharmacol 268:129-139.
28. Robinson S and Caron MG (1997) Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. Mol Pharmacol 52:508-514.
29. Rodriguez-Viacana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature (Lond) 370:527-532.
30. Rubio I, Rodriguez-Viacana P, Downward J and Wetzker R (1997) Interaction of Ras with phosphoinositide 3-kinase γ Biochem J 326:891-895
31. 2 receptors. Neuroreport 6:329-332.
32. Schlessinger J and Ullrich C (1992) Growth factor signaling by receptor tyrosine kinase. Neuron 9:383-391.
33. Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J, Smrcka A S, Thelen M, Cadwallader K, Tempst P and Hawkins PT (1997) The Gβγ sensitivity of a PI 3-K is dependent upon a tightly associated adaptor, p101. Cell 89:105-114.
34. Touhara K, Hawes BE, van Biesen T and Lefkowitz RJ (1995) G protein βγ subunits stimulate phosphorylation of Shc adapter protein. Proc Natl Acad Sci USA 92: 9284-9287.
35. van Biesen T, Hawes B, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, Luttrell LM and Lefkowitz RJ (1995) Receptor-tyrosine-kinase and Gβγ-mediated MAP kinase activation by a common signaling pathway. Nature (Lond) 376:781-784.
36. Van Biesen T, Hawes B, Raymond JR, Luttrell LM, Koch WJ and Lefkowitz RJ (1996) Go-protein α-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J Biol Chem 271:1266-1269.
37. 3 doparaine receptors. Mol Pharmacol 52:181-186.
38. 2 dopamine receptors. J Neurochem 70:2139-2146.
39. Williams NG, Zhong H and Minneman KP (1998) Differential coupling of α1-, α2-, and β adrenergic receptors to MAP kinase pathways and differentiation in trans-fected PC12 cells. J Biol Chem 273:24624-24632.
40. Zhen X, Wang H-Y, Uryu K, Cai G, Smith C and Friedman E (1998) Activation of extracellular signal (erk)-regulated kinase by D4 dopamine receptors require Src, Shc-Grb2 via Gi protein. Abs Soc Neurosci 24:340.20.
41. Zwick E, Daub H, Aoki N, Yamaguchi-Aoki Y, Tinofer I, Maly K and Ullrich A (1997) Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem 272:24767-24770.